Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Lexagene Holdings (LXXGF)

Lexagene Holdings (LXXGF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LXXGF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2000 +10.00%
on 12/31/21
0.2800 -21.43%
on 01/18/22
-0.0265 (-10.75%)
since 12/21/21
3-Month
0.2000 +10.00%
on 12/31/21
0.4781 -53.98%
on 11/05/21
-0.2000 (-47.62%)
since 10/21/21
52-Week
0.2000 +10.00%
on 12/31/21
1.2200 -81.97%
on 02/10/21
-0.6149 (-73.65%)
since 01/21/21

Most Recent Stories

More News
LexaGene Starts the Year with Additional MiQLab Sales

BEVERLY, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
LexaGene Announces Results of Annual General and Special Meeting

BEVERLY, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
LexaGene Closes Multiple MiQLab Sales

BEVERLY, Mass., Dec. 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA

BEVERLY, Mass., Nov. 24, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
Leading Veterinary Academic, Dr. Jane Sykes, Joins LexaGene Board of Directors

BEVERLY, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
LexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a Biothreat Agent

BEVERLY, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene”), a molecular diagnostics company that...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
LexaGene Receives 2021 BioTech Breakthrough Award

BEVERLY, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
LexaGene Finalizes Design of Pneumonia Panel

BEVERLY, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
LexaGene Completes First Stage of U.S. ARMY DEVCOM Agreement

BEVERLY, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)
LexaGene to Host Corporate Update on November 3

BEVERLY, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.270 (-11.48%)
LXXGF : 0.2200 (-10.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.2645
2nd Resistance Point 0.2554
1st Resistance Point 0.2507
Last Price 0.2200
1st Support Level 0.2369
2nd Support Level 0.2278
3rd Support Level 0.2231

See More

52-Week High 1.2200
Fibonacci 61.8% 0.8304
Fibonacci 50% 0.7100
Fibonacci 38.2% 0.5896
Last Price 0.2200
52-Week Low 0.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar